MASK 2017: ARIA digitally-enabled, integrated, person-centred care for rhinitis and asthma multimorbidity using real-world-evidence

J. Bousquet; S. Arnavielhe; A. Bedbrook; M. Bewick; D. Laune; E. Mathieu-Dupas; R. Murray; G. L. Onorato; J. L. Pépin; R. Picard; F. Portejoie; E. Costa; J. Fonseca; O. Lourenço; M. Morais-Almeida; A. Todo-Bom; A. A. Cruz; J. D. Silva; F. S. Serpa; M. Illario; E. Menditto; L. Cecchi; R. Monti; L. Napoli; M. T. Ventura; G. De Feo; D. Larenas-linnemann; J. M. Fuentes-Perez; Y. R. Huerta Villabolos; D. Rivero-Yeverino; E. Rodriguez-Zagal; F. Amat; I. Annesi-Maesano; I. Bosse; P. Demoly; P. Devillier; J. F. Fontaine; J. Just; T. P. Kuna; B. Samolinski; A. Valiulis; R. Emuzyte; V. Kvedariene; D. Ryan; A. Sheikh; P. Schmidt-Grendelmeier; L. Klimek; O. Pfaar; K. C. Bergmann; R. Mösges; T. Zuberbier; R. E. Roller-wirnsberger; P. Tomazic; W. J. Fokkens; N. H. Chavannes; S. Reitsma; J. M. Anto; V. Cardona; T. Dedeu; J. Mullol; T. Haahtela; J. Salimäki; S. Toppila-Salmi; E. Valovirta; B. Gemicioğlu; A. Yorgancioglu; N. Papadopoulos; E. P. Prokopakis; S. Bosnic-anticevich; R. O’Hehir; J. C. Ivancevich; H. Neffen; E. Zernotti; I. Kull; E. Melen; M. Wickman; C. Bachert; P. Hellings; S. Palkonen; C. Bindslev-Jensen; E. Eller; S. Waserman; M. Sova; G. De Vries; M. van Eerd; I. Agache; T. Casale; M. Dykewickz; R. N. Naclerio; Y. Okamoto; D. V. Wallace; MASK study group

doi:10.1186/s13601-018-0227-6

MASK 2017: ARIA digitally-enabled, integrated, person-centred care for rhinitis and asthma multimorbidity using real-world-evidence

J. Bousquet, S. Arnavielhe, A. Bedbrook, M. Bewick, D. Laune, E. Mathieu-Dupas, R. Murray, G. L. Onorato, J. L. Pépin, R. Picard, F. Portejoie, E. Costa, J. Fonseca, O. Lourenço, M. Morais-Almeida, A. Todo-Bom, A. A. Cruz, J. D. Silva, F. S. Serpa, M. IllarioE. Menditto, L. Cecchi, R. Monti, L. Napoli, M. T. Ventura, G. De Feo, D. Larenas-linnemann, J. M. Fuentes-Perez, Y. R. Huerta Villabolos, D. Rivero-Yeverino, E. Rodriguez-Zagal, F. Amat, I. Annesi-Maesano, I. Bosse, P. Demoly, P. Devillier, J. F. Fontaine, J. Just, T. P. Kuna, B. Samolinski, A. Valiulis, R. Emuzyte, V. Kvedariene, D. Ryan, A. Sheikh, P. Schmidt-Grendelmeier, L. Klimek, O. Pfaar, K. C. Bergmann, R. Mösges, T. Zuberbier, R. E. Roller-wirnsberger, P. Tomazic, W. J. Fokkens, N. H. Chavannes, S. Reitsma, J. M. Anto, V. Cardona, T. Dedeu, J. Mullol, T. Haahtela, J. Salimäki, S. Toppila-Salmi, E. Valovirta, B. Gemicioğlu, A. Yorgancioglu, N. Papadopoulos, E. P. Prokopakis, S. Bosnic-anticevich, R. O’Hehir, J. C. Ivancevich, H. Neffen, E. Zernotti, I. Kull, E. Melen, M. Wickman, C. Bachert, P. Hellings, S. Palkonen, C. Bindslev-Jensen, E. Eller, S. Waserman, M. Sova, G. De Vries, M. van Eerd, I. Agache, T. Casale, M. Dykewickz, R. N. Naclerio, Y. Okamoto, D. V. Wallace, MASK study group

Research output: Contribution to journal › Article › peer-review

113 Citations (Scopus)

27 Downloads (Pure)

Abstract

mHealth, such as apps running on consumer smart devices is becoming increasingly popular and has the potential to profoundly affect healthcare and health outcomes. However, it may be disruptive and results achieved are not always reaching the goals. Allergic Rhinitis and its Impact on Asthma (ARIA) has evolved from a guideline using the best evidence-based approach to care pathways suited to real-life using mobile technology in allergic rhinitis (AR) and asthma multimorbidity. Patients largely use over-the-counter medications dispensed in pharmacies. Shared decision making centered around the patient and based on self-management should be the norm. Mobile Airways Sentinel networK (MASK), the Phase 3 ARIA initiative, is based on the freely available MASK app (the Allergy Diary, Android and iOS platforms). MASK is available in 16 languages and deployed in 23 countries. The present paper provides an overview of the methods used in MASK and the key results obtained to date. These include a novel phenotypic characterization of the patients, confirmation of the impact of allergic rhinitis on work productivity and treatment patterns in real life. Most patients appear to self-medicate, are often non-adherent and do not follow guidelines. Moreover, the Allergy Diary is able to distinguish between AR medications. The potential usefulness of MASK will be further explored by POLLAR (Impact of Air Pollution on Asthma and Rhinitis), a new Horizon 2020 project using the Allergy Diary.

Original language	English
Article number	45
Pages (from-to)	1-21
Number of pages	21
Journal	Clinical and Translational Allergy
Volume	8
DOIs	https://doi.org/10.1186/s13601-018-0227-6
Publication status	Published - 2018
Externally published	Yes

Bibliographical note

Copyright the Author(s) 2018. Version archived for private and non-commercial use with the permission of the author/s and according to publisher conditions. For further rights please contact the publisher.

Keywords

App
ARIA
Asthma
Care pathways
MASK
mHealth
Rhinitis

Access to Document

10.1186/s13601-018-0227-6Licence: CC BY

Publisher version (open access)Final published version, 2.49 MBLicence: CC BY

Cite this

Bousquet, J., Arnavielhe, S., Bedbrook, A., Bewick, M., Laune, D., Mathieu-Dupas, E., Murray, R., Onorato, G. L., Pépin, J. L., Picard, R., Portejoie, F., Costa, E., Fonseca, J., Lourenço, O., Morais-Almeida, M., Todo-Bom, A., Cruz, A. A., Silva, J. D., Serpa, F. S., ... MASK study group (2018). MASK 2017: ARIA digitally-enabled, integrated, person-centred care for rhinitis and asthma multimorbidity using real-world-evidence. Clinical and Translational Allergy, 8, 1-21. Article 45. https://doi.org/10.1186/s13601-018-0227-6

@article{fa1fa006572a48728ec0517c2de9bde3,

title = "MASK 2017: ARIA digitally-enabled, integrated, person-centred care for rhinitis and asthma multimorbidity using real-world-evidence",

abstract = "mHealth, such as apps running on consumer smart devices is becoming increasingly popular and has the potential to profoundly affect healthcare and health outcomes. However, it may be disruptive and results achieved are not always reaching the goals. Allergic Rhinitis and its Impact on Asthma (ARIA) has evolved from a guideline using the best evidence-based approach to care pathways suited to real-life using mobile technology in allergic rhinitis (AR) and asthma multimorbidity. Patients largely use over-the-counter medications dispensed in pharmacies. Shared decision making centered around the patient and based on self-management should be the norm. Mobile Airways Sentinel networK (MASK), the Phase 3 ARIA initiative, is based on the freely available MASK app (the Allergy Diary, Android and iOS platforms). MASK is available in 16 languages and deployed in 23 countries. The present paper provides an overview of the methods used in MASK and the key results obtained to date. These include a novel phenotypic characterization of the patients, confirmation of the impact of allergic rhinitis on work productivity and treatment patterns in real life. Most patients appear to self-medicate, are often non-adherent and do not follow guidelines. Moreover, the Allergy Diary is able to distinguish between AR medications. The potential usefulness of MASK will be further explored by POLLAR (Impact of Air Pollution on Asthma and Rhinitis), a new Horizon 2020 project using the Allergy Diary.",

keywords = "App, ARIA, Asthma, Care pathways, MASK, mHealth, Rhinitis",

author = "J. Bousquet and S. Arnavielhe and A. Bedbrook and M. Bewick and D. Laune and E. Mathieu-Dupas and R. Murray and Onorato, {G. L.} and P{\'e}pin, {J. L.} and R. Picard and F. Portejoie and E. Costa and J. Fonseca and O. Louren{\c c}o and M. Morais-Almeida and A. Todo-Bom and Cruz, {A. A.} and Silva, {J. D.} and Serpa, {F. S.} and M. Illario and E. Menditto and L. Cecchi and R. Monti and L. Napoli and Ventura, {M. T.} and {De Feo}, G. and D. Larenas-linnemann and Fuentes-Perez, {J. M.} and {Huerta Villabolos}, {Y. R.} and D. Rivero-Yeverino and E. Rodriguez-Zagal and F. Amat and I. Annesi-Maesano and I. Bosse and P. Demoly and P. Devillier and Fontaine, {J. F.} and J. Just and Kuna, {T. P.} and B. Samolinski and A. Valiulis and R. Emuzyte and V. Kvedariene and D. Ryan and A. Sheikh and P. Schmidt-Grendelmeier and L. Klimek and O. Pfaar and Bergmann, {K. C.} and R. M{\"o}sges and T. Zuberbier and Roller-wirnsberger, {R. E.} and P. Tomazic and Fokkens, {W. J.} and Chavannes, {N. H.} and S. Reitsma and Anto, {J. M.} and V. Cardona and T. Dedeu and J. Mullol and T. Haahtela and J. Salim{\"a}ki and S. Toppila-Salmi and E. Valovirta and B. Gemicioğlu and A. Yorgancioglu and N. Papadopoulos and Prokopakis, {E. P.} and S. Bosnic-anticevich and R. O{\textquoteright}Hehir and Ivancevich, {J. C.} and H. Neffen and E. Zernotti and I. Kull and E. Melen and M. Wickman and C. Bachert and P. Hellings and S. Palkonen and C. Bindslev-Jensen and E. Eller and S. Waserman and M. Sova and {De Vries}, G. and {van Eerd}, M. and I. Agache and T. Casale and M. Dykewickz and Naclerio, {R. N.} and Y. Okamoto and Wallace, {D. V.} and {MASK study group}",

note = "Copyright the Author(s) 2018. Version archived for private and non-commercial use with the permission of the author/s and according to publisher conditions. For further rights please contact the publisher.",

year = "2018",

doi = "10.1186/s13601-018-0227-6",

language = "English",

volume = "8",

pages = "1--21",

journal = "Clinical and Translational Allergy",

issn = "2045-7022",

publisher = "Springer, Springer Nature",

}

Bousquet, J, Arnavielhe, S, Bedbrook, A, Bewick, M, Laune, D, Mathieu-Dupas, E, Murray, R, Onorato, GL, Pépin, JL, Picard, R, Portejoie, F, Costa, E, Fonseca, J, Lourenço, O, Morais-Almeida, M, Todo-Bom, A, Cruz, AA, Silva, JD, Serpa, FS, Illario, M, Menditto, E, Cecchi, L, Monti, R, Napoli, L, Ventura, MT, De Feo, G, Larenas-linnemann, D, Fuentes-Perez, JM, Huerta Villabolos, YR, Rivero-Yeverino, D, Rodriguez-Zagal, E, Amat, F, Annesi-Maesano, I, Bosse, I, Demoly, P, Devillier, P, Fontaine, JF, Just, J, Kuna, TP, Samolinski, B, Valiulis, A, Emuzyte, R, Kvedariene, V, Ryan, D, Sheikh, A, Schmidt-Grendelmeier, P, Klimek, L, Pfaar, O, Bergmann, KC, Mösges, R, Zuberbier, T, Roller-wirnsberger, RE, Tomazic, P, Fokkens, WJ, Chavannes, NH, Reitsma, S, Anto, JM, Cardona, V, Dedeu, T, Mullol, J, Haahtela, T, Salimäki, J, Toppila-Salmi, S, Valovirta, E, Gemicioğlu, B, Yorgancioglu, A, Papadopoulos, N, Prokopakis, EP, Bosnic-anticevich, S, O’Hehir, R, Ivancevich, JC, Neffen, H, Zernotti, E, Kull, I, Melen, E, Wickman, M, Bachert, C, Hellings, P, Palkonen, S, Bindslev-Jensen, C, Eller, E, Waserman, S, Sova, M, De Vries, G, van Eerd, M, Agache, I, Casale, T, Dykewickz, M, Naclerio, RN, Okamoto, Y, Wallace, DV & MASK study group 2018, 'MASK 2017: ARIA digitally-enabled, integrated, person-centred care for rhinitis and asthma multimorbidity using real-world-evidence', Clinical and Translational Allergy, vol. 8, 45, pp. 1-21. https://doi.org/10.1186/s13601-018-0227-6

TY - JOUR

T1 - MASK 2017

T2 - ARIA digitally-enabled, integrated, person-centred care for rhinitis and asthma multimorbidity using real-world-evidence

AU - Bousquet, J.

AU - Arnavielhe, S.

AU - Bedbrook, A.

AU - Bewick, M.

AU - Laune, D.

AU - Mathieu-Dupas, E.

AU - Murray, R.

AU - Onorato, G. L.

AU - Pépin, J. L.

AU - Picard, R.

AU - Portejoie, F.

AU - Costa, E.

AU - Fonseca, J.

AU - Lourenço, O.

AU - Morais-Almeida, M.

AU - Todo-Bom, A.

AU - Cruz, A. A.

AU - Silva, J. D.

AU - Serpa, F. S.

AU - Illario, M.

AU - Menditto, E.

AU - Cecchi, L.

AU - Monti, R.

AU - Napoli, L.

AU - Ventura, M. T.

AU - De Feo, G.

AU - Larenas-linnemann, D.

AU - Fuentes-Perez, J. M.

AU - Huerta Villabolos, Y. R.

AU - Rivero-Yeverino, D.

AU - Rodriguez-Zagal, E.

AU - Amat, F.

AU - Annesi-Maesano, I.

AU - Bosse, I.

AU - Demoly, P.

AU - Devillier, P.

AU - Fontaine, J. F.

AU - Just, J.

AU - Kuna, T. P.

AU - Samolinski, B.

AU - Valiulis, A.

AU - Emuzyte, R.

AU - Kvedariene, V.

AU - Ryan, D.

AU - Sheikh, A.

AU - Schmidt-Grendelmeier, P.

AU - Klimek, L.

AU - Pfaar, O.

AU - Bergmann, K. C.

AU - Mösges, R.

AU - Zuberbier, T.

AU - Roller-wirnsberger, R. E.

AU - Tomazic, P.

AU - Fokkens, W. J.

AU - Chavannes, N. H.

AU - Reitsma, S.

AU - Anto, J. M.

AU - Cardona, V.

AU - Dedeu, T.

AU - Mullol, J.

AU - Haahtela, T.

AU - Salimäki, J.

AU - Toppila-Salmi, S.

AU - Valovirta, E.

AU - Gemicioğlu, B.

AU - Yorgancioglu, A.

AU - Papadopoulos, N.

AU - Prokopakis, E. P.

AU - Bosnic-anticevich, S.

AU - O’Hehir, R.

AU - Ivancevich, J. C.

AU - Neffen, H.

AU - Zernotti, E.

AU - Kull, I.

AU - Melen, E.

AU - Wickman, M.

AU - Bachert, C.

AU - Hellings, P.

AU - Palkonen, S.

AU - Bindslev-Jensen, C.

AU - Eller, E.

AU - Waserman, S.

AU - Sova, M.

AU - De Vries, G.

AU - van Eerd, M.

AU - Agache, I.

AU - Casale, T.

AU - Dykewickz, M.

AU - Naclerio, R. N.

AU - Okamoto, Y.

AU - Wallace, D. V.

AU - MASK study group

N1 - Copyright the Author(s) 2018. Version archived for private and non-commercial use with the permission of the author/s and according to publisher conditions. For further rights please contact the publisher.

PY - 2018

Y1 - 2018

N2 - mHealth, such as apps running on consumer smart devices is becoming increasingly popular and has the potential to profoundly affect healthcare and health outcomes. However, it may be disruptive and results achieved are not always reaching the goals. Allergic Rhinitis and its Impact on Asthma (ARIA) has evolved from a guideline using the best evidence-based approach to care pathways suited to real-life using mobile technology in allergic rhinitis (AR) and asthma multimorbidity. Patients largely use over-the-counter medications dispensed in pharmacies. Shared decision making centered around the patient and based on self-management should be the norm. Mobile Airways Sentinel networK (MASK), the Phase 3 ARIA initiative, is based on the freely available MASK app (the Allergy Diary, Android and iOS platforms). MASK is available in 16 languages and deployed in 23 countries. The present paper provides an overview of the methods used in MASK and the key results obtained to date. These include a novel phenotypic characterization of the patients, confirmation of the impact of allergic rhinitis on work productivity and treatment patterns in real life. Most patients appear to self-medicate, are often non-adherent and do not follow guidelines. Moreover, the Allergy Diary is able to distinguish between AR medications. The potential usefulness of MASK will be further explored by POLLAR (Impact of Air Pollution on Asthma and Rhinitis), a new Horizon 2020 project using the Allergy Diary.

AB - mHealth, such as apps running on consumer smart devices is becoming increasingly popular and has the potential to profoundly affect healthcare and health outcomes. However, it may be disruptive and results achieved are not always reaching the goals. Allergic Rhinitis and its Impact on Asthma (ARIA) has evolved from a guideline using the best evidence-based approach to care pathways suited to real-life using mobile technology in allergic rhinitis (AR) and asthma multimorbidity. Patients largely use over-the-counter medications dispensed in pharmacies. Shared decision making centered around the patient and based on self-management should be the norm. Mobile Airways Sentinel networK (MASK), the Phase 3 ARIA initiative, is based on the freely available MASK app (the Allergy Diary, Android and iOS platforms). MASK is available in 16 languages and deployed in 23 countries. The present paper provides an overview of the methods used in MASK and the key results obtained to date. These include a novel phenotypic characterization of the patients, confirmation of the impact of allergic rhinitis on work productivity and treatment patterns in real life. Most patients appear to self-medicate, are often non-adherent and do not follow guidelines. Moreover, the Allergy Diary is able to distinguish between AR medications. The potential usefulness of MASK will be further explored by POLLAR (Impact of Air Pollution on Asthma and Rhinitis), a new Horizon 2020 project using the Allergy Diary.

KW - App

KW - ARIA

KW - Asthma

KW - Care pathways

KW - MASK

KW - mHealth

KW - Rhinitis

UR - http://www.scopus.com/inward/record.url?eid=2-s2.0-85055564214&partnerID=MN8TOARS

U2 - 10.1186/s13601-018-0227-6

DO - 10.1186/s13601-018-0227-6

M3 - Article

C2 - 30386555

SN - 2045-7022

VL - 8

SP - 1

EP - 21

JO - Clinical and Translational Allergy

JF - Clinical and Translational Allergy

M1 - 45

ER -

MASK 2017: ARIA digitally-enabled, integrated, person-centred care for rhinitis and asthma multimorbidity using real-world-evidence

Abstract

Bibliographical note

Keywords

Access to Document

Other files and links

Fingerprint

Cite this